Institute of Medicine report called the pattern of higher rates of disease and shorter lives “the U.S. health disadvantage,” and said it was responsible for dragging the country to the bottom in terms of life expectancy over the past 30 years. Continue reading →
Bloomberg News conducted a data review of payroll records for 1.4 million public employees of the 12 largest states. The findings show that public employees in California earn far higher salaries than in other states, from prison operations to health care, base . . . Continue reading →
Physicians at Sloan Kettering Cancer Center have taken a giant step toward stemming the tide of unconscionable pharmaceutical industry price gouging. Sloan-Kettering physicians said NO to Sanofi’s new anti-cancer drug, Zaltrap which the company priced at $11,063 per month. Drs. Peter B. . . . Continue reading →
TIME Psychiatrist Contends the Field Is ‘Committing Professional Suicide’ Psychiatry — and medicine in general — has a dangerously close relationship with the pharmaceutical industry Maia Szalavitz | @maiasz | October 5, 2012 | British psychiatrist and Big Pharma gadfly David Healy . . . Continue reading →
Update: America’s Healthcare Crisis–7 Scientists Quit Cancer Prevention Research Institute of Texas Continue reading →
Respected international scientists who examined the evidence, concluded that annual influenza campaigns are likely an utter waste of time and money." But officials at the US Centers for Disease Control disregard science and accept commercial propaganda as their guide for setting public health policy.
Continue reading →
FDA, a complicit partner in crimes and corrupt industry practices have resulted in an epidemic of preventable injuries and deaths. Continue reading →
Part III. The Untouchable Third Rail in Healthcare—The Vaccine Controversy: Core Issues Continue reading →
Even if retracted, published clinical trial reports that misrepresent findings, withhold negative data, or make false, or unsubstantiated claims have done irreparable damage. AHRP calls upon all medical journals to adopt a publication policy requiring submission of the sponsor’s formal Clinical Study Report to accompany articles about clinical trial findings.
On Friday, April 6, the FDA approved another of Eli Lilly’s "breakthroughs" whose clinical value is questionable (at best). Continue reading →
“Overuse is one of the most serious crises in American medicine.” The crisis is not only of misspending of resources, overuse of medical treatments is causing treatment-produced harm, including preventable deaths.